August 8, 2013 / 1:56 PM / 6 years ago

REFILE-Biotech company Intrexon shares surge 38 pct in debut

Aug 8 (Reuters) - Biotechnology company Intrexon Corp’s shares rose as much as 38 percent in their market debut, valuing the company at more than $2 billion.

Intrexon raised $160 million after its initial public offering of 10 million shares was priced at $16 each, at the high end of the expected range.

The company’s shares were trading at $22.36 on the New York Stock Exchange. About 1.9 million shares had changed hands at 0952 ET. The stock was the top percentage gainer on the exchange.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below